SP2 and acute myeloid leukemia: The transcriptional activity of SP1 and SP2 was unaffected by METTL3 deletion, but due to the lack of m6A modification on the transcripts, the transcripts were shifted to low molecular weight polyribosomes, resulting in reduced translational efficiency and less protein production, ultimately leading to reduced malignancy of AML cells.